Follow
Eva van Rooij
Eva van Rooij
Group leader Hubrecht Institute
Verified email at hubrecht.eu - Homepage
Title
Cited by
Cited by
Year
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
E Van Rooij, LB Sutherland, JE Thatcher, JM DiMaio, RH Naseem, ...
Proceedings of the National Academy of Sciences 105 (35), 13027-13032, 2008
22452008
Control of stress-dependent cardiac growth and gene expression by a microRNA
E Van Rooij, LB Sutherland, X Qi, JA Richardson, J Hill, EN Olson
science 316 (5824), 575-579, 2007
20702007
A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure
E Van Rooij, LB Sutherland, N Liu, AH Williams, J McAnally, RD Gerard, ...
Proceedings of the National Academy of Sciences 103 (48), 18255-18260, 2006
19382006
A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance
E van Rooij, D Quiat, BA Johnson, LB Sutherland, X Qi, JA Richardson, ...
Developmental cell 17 (5), 662-673, 2009
11212009
MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles
E Van Rooij, EN Olson
Nature reviews Drug discovery 11 (11), 860-872, 2012
7442012
Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21
ME Hatley, DM Patrick, MR Garcia, JA Richardson, R Bassel-Duby, ...
Cancer cell 18 (3), 282-293, 2010
7432010
Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure
RL Montgomery, TG Hullinger, HM Semus, BA Dickinson, AG Seto, ...
Circulation 124 (14), 1537-1547, 2011
7132011
Development of micro RNA therapeutics is coming of age
E Van Rooij, S Kauppinen
EMBO molecular medicine 6 (7), 851-864, 2014
7002014
The art of microRNA research
E Van Rooij
Circulation research 108 (2), 219-234, 2011
6932011
MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets
E Van Rooij, EN Olson
The Journal of clinical investigation 117 (9), 2369-2376, 2007
6772007
Developing microRNA therapeutics
E van Rooij, AL Purcell, AA Levin
Circulation research 110 (3), 496-507, 2012
6272012
Inhibition of miR-15 protects against cardiac ischemic injury
TG Hullinger, RL Montgomery, AG Seto, BA Dickinson, HM Semus, ...
Circulation research 110 (1), 71-81, 2012
5892012
Toward microrna–based therapeutics for heart disease: The sense in antisense
E Van Rooij, WS Marshall, EN Olson
Circulation research 103 (9), 919-928, 2008
5102008
MiR-15 family regulates postnatal mitotic arrest of cardiomyocytes
ER Porrello, BA Johnson, AB Aurora, E Simpson, YJ Nam, SJ Matkovich, ...
Circulation research 109 (6), 670-679, 2011
5062011
Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice
DM Patrick, RL Montgomery, X Qi, S Obad, S Kauppinen, JA Hill, ...
The Journal of clinical investigation 120 (11), 3912-3916, 2010
4592010
MicroRNAs flex their muscles
E van Rooij, N Liu, EN Olson
Trends in Genetics 24 (4), 159-166, 2008
4492008
MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca2+ overload and cell death
AB Aurora, AI Mahmoud, X Luo, BA Johnson, E Van Rooij, S Matsuzaki, ...
The Journal of clinical investigation 122 (4), 2012
4432012
MicroRNA control of muscle development and disease
AH Williams, N Liu, E Van Rooij, EN Olson
Current opinion in cell biology 21 (3), 461-469, 2009
4122009
Inhibition of microRNA-92a protects against ischemia/reperfusion injury in a large-animal model
R Hinkel, D Penzkofer, S Zühlke, A Fischer, W Husada, QF Xu, E Baloch, ...
Circulation 128 (10), 1066-1075, 2013
3862013
A cardiac microRNA governs systemic energy homeostasis by regulation of MED13
CE Grueter, E Van Rooij, BA Johnson, SM DeLeon, LB Sutherland, X Qi, ...
Cell 149 (3), 671-683, 2012
3842012
The system can't perform the operation now. Try again later.
Articles 1–20